Nrf2 as regulator of innate immunity: A molecular Swiss army knife!

Biotechnology Advances

Volumn 36, Issue 2, 2018, Pages 358-370

  Battino, Maurizio ^a   Giampieri, Francesca ^a   Pistollato, Francesca ⁱ   Sureda, Antoni ^b   de Oliveira, Marcos Roberto ^c   Pittalà, Valeria ^d   Fallarino, Francesca ^e   Nabavi, Seyed Fazel ^f   Atanasov, Atanas Georgiev ^g,h   Nabavi, Seyed Mohammad ^f  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITAT DE LES ILLES BALEARS   (Spain)

^c FEDERAL UNIVERSITY OF MATO GROSSO   (Brazil)

^d UNIVERSITY OF CATANIA   (Italy)

^e UNIVERSITY OF PERUGIA   (Italy)

^f BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^g UNIVERSITY OF VIENNA   (Austria)

^h INSTITUTE OF GENETICS AND ANIMAL BREEDING   (Poland)

ⁱ Parque Científico y Tecnológico de Cantabria   (Spain)

Author keywords

Immune system; Inflammation; Natural compounds; Nuclear factor; Oxidative stress

Indexed keywords

AGENTS; ALLERGENS; AMINO ACIDS; CHEMICAL COMPOUNDS; GENE EXPRESSION; GENES; OXIDATIVE STRESS; PATHOGENS; PATTERN RECOGNITION SYSTEMS; PHYSIOLOGY; TRANSCRIPTION; TRANSCRIPTION FACTORS;

BASIC LEUCINE ZIPPERS (BZIP); ENVIRONMENTAL CHEMICALS; INFLAMMATION; NATURAL COMPOUNDS; NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2; NUCLEAR FACTORS; PATHOGEN-ASSOCIATED MOLECULAR PATTERNS; STRUCTURE AND ACTIVITIES;

IMMUNE SYSTEM;

ANTIOXIDANT; CELL; GENE; GENE EXPRESSION; HOMEOSTASIS; IMMUNE SYSTEM; IMMUNITY; OXIDATIVE STRESS; PATHOGEN; PHYSIOLOGICAL RESPONSE; TOXICITY;

TRANSCRIPTION FACTOR NRF2;

ANIMAL; HUMAN; INFLAMMATION; INNATE IMMUNITY; MOUSE; OXIDATIVE STRESS; PHYSIOLOGY; RAT; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; IMMUNITY, INNATE; INFLAMMATION; MICE; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; RATS; SIGNAL TRANSDUCTION;

EID: 85039146938     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2017.12.012     Document Type: Review

References (210)

1. Akira, S., Uematsu, S., Takeuchi, O., Pathogen recognition and innate immunity. Cell 124 (2006), 783–801.
2. Alam, J., Stewart, D., Touchard, C., Boinapally, S., Choi, A.M., Cook, J.L., Nrf2, a Cap ‘n’ Collar transcription factor, regulates induction of the heme oxygenase-1 gene. J. Biol. Chem. 274 (1999), 26071–26078.
3. Amata, E., Pittala, V., Marrazzo, A., Parenti, C., Prezzavento, O., Arena, E. et al., Role of the Nrf2/HO-1 axis in bronchopulmonary dysplasia and hyperoxic lung injuries. Clin. Sci. 131 (2017), 1701–1712.
4. An, Y.W., Jhang, K.A., Woo, S.Y., Kang, J.L., Chong, Y.H., Sulforaphane exerts its anti-inflammatory effect against amyloid-β peptide via STAT-1 dephosphorylation and activation of Nrf2/HO-1 cascade in human THP-1 macrophages. Neurobiol. Aging 38 (2016), 1–10.
5. Arnér, E.S., Focus on mammalian thioredoxin reductases—important selenoproteins with versatile functions. Biochim. Biophys. Acta 1790 (2009), 495–526.
6. Baird, L., Dinkova-Kostova, A.T., The cytoprotective role of the Keap1–Nrf2 pathway. Arch. Toxicol. 85 (2011), 241–272.
7. Baird, L., Lleres, D., Swift, S., Dinkova-Kostova, A.T., Regulatory flexibility in the Nrf2-mediated stress response is conferred by conformational cycling of the Keap1-Nrf2 protein complex. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 15259–15264.
8. Baird, L., Swift, S., Lleres, D., Dinkova-Kostova, A.T., Monitoring Keap1-Nrf2 interactions in single live cells. Biotechnol. Adv. 32 (2014), 1133–1144.
9. Bassermann, F., Eichner, R., Pagano, M., The ubiquitin proteasome system - implications for cell cycle control and the targeted treatment of cancer. Biochim. Biophys. Acta 1843 (2014), 150–162.
10. Bellezza, I., Tucci, A., Galli, F., Grottelli, S., Mierla, A.L., Pilolli, F. et al., Inhibition of NF-κB nuclear translocation via HO-1 activation underlies α-tocopheryl succinate toxicity. J. Nutr. Biochem. 23 (2012), 1583–1591.
11. Benchekroun, M., Romero, A., Egea, J., Leon, R., Michalska, P., Buendia, I. et al., The antioxidant additive approach for alzheimer's disease therapy: new ferulic (lipoic) acid plus melatonin modified tacrines as cholinesterases inhibitors, direct antioxidants, and nuclear factor (erythroid-derived 2)-like 2 activators. J. Med. Chem. 59 (2016), 9967–9973.
12. Bhattarai, G., Poudel, S.B., Kook, S.H., Lee, J.C., Resveratrol prevents alveolar bone loss in an experimental rat model of periodontitis. Acta Biomater. 29 (2016), 398–408.
13. Bianchi, M.E., DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol. 81 (2007), 1–5.
14. Bock, K.W., Köhle, C., UDP-glucuronosyltransferase 1A6: structural, functional, and regulatory aspects. Methods Enzymol. 400 (2005), 57–75.
15. Boutten, A., Goven, D., Artaud-Macari, E., Boczkowski, J., Bonay, M., NRF2 targeting: a promising therapeutic strategy in chronic obstructive pulmonary disease. Trends Mol. Med. 17 (2011), 363–371.
16. Boyanapalli, S.S., Paredes-Gonzalez, X., Fuentes, F., Zhang, C., Guo, Y., Pung, D. et al., Nrf2 knockout attenuates the anti-inflammatory effects of phenethyl isothiocyanate and curcumin. Chem. Res. Toxicol. 27 (2014), 2036–2043.
17. Bryan, H.K., Olayanju, A., Goldring, C.E., Park, B.K., The Nrf2 cell defence pathway: Keap1-dependent and-independent mechanisms of regulation. Biochem. Pharmacol. 85 (2013), 705–717.
18. Caboni, P., Sherer, T.B., Zhang, N., Taylor, G., Na, H.M., Greenamyre, J.T. et al., Rotenone, deguelin, their metabolites, and the rat model of Parkinson's disease. Chem. Res. Toxicol. 17 (2004), 1540–1548.
19. Cabrera, M., Mastandrea, I., Otero, G., Cerecetto, H., Gonzalez, M., In vivo phase II-enzymes inducers, as potential chemopreventive agents, based on the chalcone and furoxan skeletons. Bioorg. Med. Chem. 24 (2016), 1665–1674.
20. Cader, M.Z., Kaser, A., Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation. Gut 62 (2013), 1653–1664.
21. Canning, P., Cooper, C.D., Krojer, T., Murray, J.W., Pike, A.C., Chaikuad, A. et al., Structural basis for Cul3 protein assembly with the BTB-Kelch family of E3 ubiquitin ligases. J. Biol. Chem. 288 (2013), 7803–7814.
22. Cao, T.H., Jin, S.G., Fei, D.S., Kang, K., Jiang, L., Lian, Z.Y. et al., Artesunate protects against sepsis-induced lung injury via heme oxygenase-1 modulation. Inflammation 39 (2016), 651–662.
23. Capiralla, H., Vingtdeux, V., Zhao, H., Sankowski, R., Al-Abed, Y., Davies, P. et al., Resveratrol mitigates lipopolysaccharide-and Aβ-mediated microglial inflammation by inhibiting the TLR4/NF-κB/STAT signaling cascade. J. Neurochem. 120 (2012), 461–472.
24. Chanas, S.A., Jiang, Q., Mcmahon, M., Mcwalter, G.K., Mclellan, L.I., Elcombe, C.R. et al., Loss of the Nrf2 transcription factor causes a marked reduction in constitutive and inducible expression of the glutathione S-transferase Gsta1, Gsta2, Gstm1, Gstm2, Gstm3 and Gstm4 genes in the livers of male and female mice. Biochem. J. 365 (2002), 405–416.
25. Chang, K.M., Chen, H.H., Wang, T.C., Chen, I.L., Chen, Y.T., Yang, S.C. et al., Novel oxime-bearing coumarin derivatives act as potent Nrf2/ARE activators in vitro and in mouse model. Eur. J. Med. Chem. 106 (2015), 60–74.
26. Chang, K.M., Liang, F.P., Chen, I.L., Yang, S.C., Juang, S.H., Wang, T.C. et al., Discovery of oxime-bearing naphthalene derivatives as a novel structural type of Nrf2 activators. Bioorg. Med. Chem. 23 (2015), 3852–3859.
27. Chen, W., Sun, Z., Wang, X.J., Jiang, T., Huang, Z., Fang, D. et al., Direct interaction between Nrf2 and p21 Cip1/WAF1 upregulates the Nrf2-mediated antioxidant response. Mol. Cell 34 (2009), 663–673.
28. Cheng, L., Jin, Z., Zhao, R., Ren, K., Deng, C., Yu, S., Resveratrol attenuates inflammation and oxidative stress induced by myocardial ischemia-reperfusion injury: role of Nrf2/ARE pathway. Int. J. Clin. Exp. Med., 8, 2015, 10420.
29. Cheng, L., Li, F., Ma, R., Hu, X., Forsythiaside inhibits cigarette smoke-induced lung inflammation by activation of Nrf2 and inhibition of NF-κB. Int. Immunopharmacol. 28 (2015), 494–499.
30. Cleasby, A., Yon, J., Day, P.J., Richardson, C., Tickle, I.J., Williams, P.A. et al., Structure of the BTB domain of Keap1 and its interaction with the triterpenoid antagonist CDDO. PLoS One, 9, 2014, e98896.
31. Clements, C.M., McNally, R.S., Conti, B.J., Mak, T.W., Ting, J.P.Y., DJ-1, a cancer-and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 15091–15096.
32. Colville-Nash, P.R., Qureshi, S.S., Willis, D., Willoughby, D.A., Inhibition of inducible nitric oxide synthase by peroxisome proliferator-activated receptor agonists: correlation with induction of heme oxygenase 1. J. Immunol. 161 (1998), 978–984.
33. Cominacini, L., Mozzini, C., Garbin, U., Pasini, A., Stranieri, C., Solani, E. et al., Endoplasmic reticulum stress and Nrf2 signaling in cardiovascular diseases. Free Radic. Biol. Med. 88 (2015), 233–242.
34. Cui, Y., Liu, K.W., Liang, Y., Ip, M.S., Mak, J.C., Inhibition of monoamine oxidase-B by selegiline reduces cigarette smoke-induced oxidative stress and inflammation in airway epithelial cells. Toxicol. Lett. 268 (2017), 44–50.
35. Cullinan, S.B., Gordan, J.D., Jin, J., Harper, J.W., Diehl, J.A., The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase. Mol. Cell. Biol. 24 (2004), 8477–8486.
36. Das, J., Ramani, R., Suraju, M.O., Polyphenol compounds and PKC signaling. Biochim. Biophys. Acta 1860 (2016), 2107–2121.
37. Deny, L.J., Traboulsi, H., Cantin, A.M., Marsault, E., Richter, M.V., Belanger, G., Bis-michael acceptors as novel probes to study the Keap1/Nrf2/ARE pathway. J. Med. Chem. 59 (2016), 9431–9442.
38. Deshmukh, P., Unni, S., Krishnappa, G., Padmanabhan, B., The Keap1-Nrf2 pathway: promising therapeutic target to counteract ROS-mediated damage in cancers and neurodegenerative diseases. Biophys. Rev. 9 (2017), 41–56.
39. Dinkova-Kostova, A.T., Holtzclaw, W.D., Cole, R.N., Itoh, K., Wakabayashi, N., Katoh, Y. et al., Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc. Natl. Acad. Sci. U. S. A. 99 (2002), 11908–11913.
40. Dong, Z., Shang, H., Chen, Y.Q., Pan, L.L., Bhatia, M., Sun, J., Sulforaphane protects pancreatic acinar cell injury by modulating Nrf2-mediated oxidative stress and NLRP3 inflammatory pathway. Oxidative Med. Cell. Longev., 2016, 2016, 7864150.
41. Dowson, C., Simpson, N., Duffy, L., O'Reilly, S., Innate immunity in systemic sclerosis. Curr. Rheumatol. Rep., 19(2), 2017.
42. El Ali, Z., Gerbeix, C., Hemon, P., Esser, P.R., Martin, S.F., Pallardy, M. et al., Allergic skin inflammation induced by chemical sensitizers is controlled by the transcription factor Nrf2. Toxicol. Sci. 134 (2013), 39–48.
43. Elliott, D.E., Siddique, S.S., Weinstock, J.V., Innate immunity in disease. Clin. Gastroenterol. Hepatol. 12 (2014), 749–755.
44. Esmaeili, M.A., Alilou, M., Naringenin attenuates CCl4-induced hepatic inflammation by the activation of an Nrf2-mediated pathway in rats. Clin. Exp. Pharmacol. Physiol. 41 (2014), 416–422.
45. Gao, Z., Han, Y., Hu, Y., Wu, X., Wang, Y., Zhang, X. et al., Targeting HO-1 by epigallocatechin-3-gallate reduces contrast-induced renal injury via anti-oxidative stress and anti-inflammation pathways. PLoS One, 11, 2016, e0149032.
46. Giudice, A., Montella, M., Activation of the Nrf2–ARE signaling pathway: a promising strategy in cancer prevention. BioEssays 28 (2006), 169–181.
47. Gomez, J.C., Dang, H., Martin, J.R., Doerschuk, C.M., Nrf2 modulates host defense during streptococcus pneumoniae pneumonia in mice. J. Immunol., 1600043, 2016.
48. Goodale, B.C., Rayack, E.J., Stanton, B.A., Arsenic alters transcriptional responses to Pseudomonas aeruginosa infection and decreases antimicrobial defense of human airway epithelial cells. Toxicol. Appl. Pharmacol. 331 (2017), 154–163.
49. Gorrini, C., Harris, I.S., Mak, T.W., Modulation of oxidative stress as an anticancer strategy. Nat. Rev. Drug Discov. 12 (2013), 931–947.
50. Guillot-Sestier, M.V., Doty, K.R., Town, T., Innate immunity fights Alzheimer's disease. Trends Neurosci. 38 (2015), 674–681.
51. Gullotta, F., di Masi, A., Coletta, M., Ascenzi, P., CO metabolism, sensing, and signaling. Biofactors 38 (2012), 1–13.
52. Guo, C., Yang, L., Wan, C.X., Xia, Y.Z., Zhang, C., Chen, M.H. et al., Anti-neuroinflammatory effect of Sophoraflavanone G from Sophora alopecuroides in LPS-activated BV2 microglia by MAPK, JAK/STAT and Nrf2/HO-1 signaling pathways. Phytomedicine 23 (2016), 1629–1637.
53. Han, E.S., Muller, F.L., Pérez, V.I., Qi, W., Liang, H., Xi, L. et al., The in vivo gene expression signature of oxidative stress. Physiol. Genomics 34 (2008), 112–126.
54. Hato, T., Dagher, P.C., How the innate immune system senses trouble and causes trouble. Clin. J. Am. Soc. Nephrol. 10 (2015), 1459–1469.
55. Hayes, J.D., Dinkova-Kostova, A.T., The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends Biochem. Sci. 39 (2014), 199–218.
56. Hirotsu, Y., Katsuoka, F., Funayama, R., Nagashima, T., Nishida, Y., Nakayama, K. et al., Nrf2-MafG heterodimers contribute globally to antioxidant and metabolic networks. Nucleic Acids Res. 40 (2012), 10228–10239.
57. Hong, Y.A., Lim, J.H., Kim, M.Y., Kim, E.N., Koh, E.S., Shin, S.J. et al., Delayed treatment with oleanolic acid attenuates tubulointerstitial fibrosis in chronic cyclosporine nephropathy through Nrf2/HO-1 signaling. J. Transl. Med., 12, 2014, 50.
58. Huang, H., Falgout, B., Takeda, K., Yamada, K.M., Dhawan, S., Nrf2-dependent induction of innate host defense via heme oxygenase-1 inhibits Zika virus replication. Virology 503 (2017), 1–5.
59. Iwasaki, A., Medzhitov, R., Control of adaptive immunity by the innate immune system. Nat. Immunol. 16 (2015), 343–353.
60. Jain, A.K., Jaiswal, A.K., Phosphorylation of tyrosine 568 controls nuclear export of Nrf2. J. Biol. Chem. 281 (2006), 12132–12142.
61. Jeong, W.S., Jun, M., Kong, A.N.T., Nrf2: a potential molecular target for cancer chemoprevention by natural compounds. Antioxid. Redox Signal. 8 (2006), 99–106.
62. Jiang, W., Luo, F., Lu, Q., Liu, J., Li, P., Wang, X. et al., The protective effect of Trillin LPS-induced acute lung injury by the regulations of inflammation and oxidative state. Chem. Biol. Interact. 243 (2016), 127–134.
63. Jiang, Z.Y., Lu, M.C., You, Q.D., Discovery and development of Kelch-like ECH-associated protein 1. Nuclear factor erythroid 2-related factor 2 (KEAP1:NRF2) protein–protein interaction inhibitors: achievements, challenges, and future directions. J. Med. Chem. 59 (2016), 10837–10858.
64. Johnson, J.A., Johnson, D.A., Kraft, A.D., Calkins, M.J., Jakel, R.J., Vargas, M.R. et al., The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration. Ann. N. Y. Acad. Sci. 1147 (2008), 61–69.
65. Johnson, D.A., Amirahmadi, S., Ward, C., Fabry, Z., Johnson, J.A., The absence of the pro-antioxidant transcription factor Nrf2 exacerbates experimental autoimmune encephalomyelitis. Toxicol. Sci. 114 (2010), 237–246.
66. Joung, E.J., Lee, B., Gwon, W.G., Shin, T., Jung, B.M., Yoon, N.Y. et al., Sargaquinoic acid attenuates inflammatory responses by regulating NF-κB and Nrf2 pathways in lipopolysaccharide-stimulated RAW 264.7 cells. Int. Immunopharmacol. 29 (2015), 693–700.
67. Juncadella, I.J., Kadl, A., Sharma, A.K., Shim, Y.M., Hochreiter-Hufford, A., Borish, L. et al., Apoptotic cell clearance by bronchial epithelial cells critically influences airway inflammation. Nature 493 (2013), 547–551.
68. Jung, J.S., Choi, M.J., Lee, Y.Y., Moon, B.I., Park, J.S., Kim, H.S., Suppression of lipopolysaccharide-induced neuroinflammation by morin via MAPK, PI3K/Akt, and PKA/HO-1 signaling pathway modulation. J. Agric. Food Chem. 65 (2017), 373–382.
69. Kalinina, E., Chernov, N., Novichkova, M., Role of glutathione, glutathione transferase, and glutaredoxin in regulation of redox-dependent processes. Biochemistry 79 (2014), 1562–1583.
70. Kang, H.J., Hong, Y.B., Kim, H.J., Bae, I., CR6-interacting factor 1 (CRIF1) regulates NF-E2-related factor 2 (NRF2) protein stability by proteasome-mediated degradation. J. Biol. Chem. 285 (2010), 21258–21268.
71. Kaspar, J.W., Niture, S.K., Jaiswal, A.K., Nrf2: INrf2 (Keap1) signaling in oxidative stress. Free Radic. Biol. Med. 47 (2009), 1304–1309.
72. Katoh, Y., Itoh, K., Yoshida, E., Miyagishi, M., Fukamizu, A., Yamamoto, M., Two domains of Nrf2 cooperatively bind CBP, a CREB binding protein, and synergistically activate transcription. Genes Cells 6 (2001), 857–868.
73. Kawai, T., Akira, S., The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11 (2010), 373–384.
74. Kensler, T.W., Wakabayashi, N., Nrf2: friend or foe for chemoprevention?. Carcinogenesis 31 (2010), 90–99.
75. Keum, Y.S., Choi, B.Y., Molecular and chemical regulation of the Keap1-Nrf2 signaling pathway. Molecules 19 (2014), 10074–10089.
76. Kim, A.N., Jeon, W.K., Lee, J.J., Kim, B.C., Up-regulation of heme oxygenase-1 expression through CaMKII-ERK1/2-Nrf2 signaling mediates the anti-inflammatory effect of bisdemethoxycurcumin in LPS-stimulated macrophages. Free Radic. Biol. Med. 49 (2010), 323–331.
77. Kim, S.S., Lim, J., Bang, Y., Gal, J., Lee, S.U., Cho, Y.C. et al., Licochalcone E activates Nrf2/antioxidant response element signaling pathway in both neuronal and microglial cells: therapeutic relevance to neurodegenerative disease. J. Nutr. Biochem. 23 (2012), 1314–1323.
78. Kim, Y.M., Kim, H.J., Chang, K.C., Glycyrrhizin reduces HMGB1 secretion in lipopolysaccharide-activated RAW 264.7 cells and endotoxemic mice by p38/Nrf2-dependent induction of HO-1. Int. Immunopharmacol. 26 (2015), 112–118.
79. Kim, C.S., Choi, H.S., Joe, Y., Chung, H.T., Yu, R., Induction of heme oxygenase-1 with dietary quercetin reduces obesity-induced hepatic inflammation through macrophage phenotype switching. Nutr. Res. Pract. 10 (2016), 623–628.
80. Kim, K.S., Lee, D.S., Kim, D.C., Yoon, C.S., Ko, W., Oh, H. et al., Anti-Inflammatory effects and mechanisms of action of coussaric and betulinic acids isolated from Diospyros kaki in lipopolysaccharide-stimulated RAW 264.7 macrophages. Molecules, 21, 2016, 1206.
81. Kobayashi, M., Yamamoto, M., Nrf2–Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species. Adv. Enzym. Regul. 46 (2006), 113–140.
82. Komatsu, M., Kurokawa, H., Waguri, S., Taguchi, K., Kobayashi, A., Ichimura, Y. et al., The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat. Cell Biol. 12 (2010), 213–223.
83. Kumar, V., Kumar, S., Hassan, M., Wu, H., Thimmulappa, R.K., Kumar, A. et al., Novel chalcone derivatives as potent Nrf2 activators in mice and human lung epithelial cells. J. Med. Chem. 54 (2011), 4147–4159.
84. Kumar, H., Koppula, S., Kim, I.S., Vasant More, S., Kim, B.W., Choi, D.K., Nuclear factor erythroid 2-related factor 2 signaling in Parkinson disease: a promising multi therapeutic target against oxidative stress, neuroinflammation and cell death. CNS Neurol. Disord. Drug Targets 11 (2012), 1015–1029.
85. Kumar, K.S., Yang, H.L., Tsai, Y.C., Hung, P.C., Chang, S.H., Lo, H.W. et al., Lucidone protects human skin keratinocytes against free radical-induced oxidative damage and inflammation through the up-regulation of HO-1/Nrf2 antioxidant genes and down-regulation of NF-κB signaling pathway. Food Chem. Toxicol. 59 (2013), 55–66.
86. Kumar, H., Kim, I.S., More, S.V., Kim, B.W., Choi, D.K., Natural product-derived pharmacological modulators of Nrf2/ARE pathway for chronic diseases. Nat. Prod. Rep. 31 (2014), 109–139.
87. Kwak, M.K., Itoh, K., Yamamoto, M., Sutter, T.R., Kensler, T.W., Role of transcription factor Nrf2 in the induction of hepatic phase 2 and antioxidative enzymes in vivo by the cancer chemoprotective agent, 3H-1, 2-dimethiole-3-thione. Mol. Med. 7 (2001), 135–145.
88. Lau, A., Villeneuve, N.F., Sun, Z., Wong, P.K., Zhang, D.D., Dual roles of Nrf2 in cancer. Pharmacol. Res. 58 (2008), 262–270.
89. Lee, O.H., Jain, A.K., Papusha, V., Jaiswal, A.K., An auto-regulatory loop between stress sensors INrf2 and Nrf2 controls their cellular abundance. J. Biol. Chem. 282 (2007), 36412–36420.
90. Lee, B.H., Hsu, W.H., Huang, T., Chang, Y.Y., Hsu, Y.W., Pan, T.M., Effects of monascin on anti-inflammation mediated by Nrf2 activation in advanced glycation end product-treated THP-1 monocytes and methylglyoxal-treated Wistar rats. J. Agric. Food Chem. 61 (2013), 1288–1298.
91. Lee, D., Bae, J., Kim, Y.K., Gil, M., Lee, J.Y., Park, C.S. et al., Inhibitory effects of berberine on lipopolysaccharide-induced inducible nitric oxide synthase and the high-mobility group box 1 release in macrophages. Biochem. Biophys. Res. Commun. 431 (2013), 506–511.
92. Lee, J.W., Choi, Y.J., Park, J.H., Sim, J.Y., Kwon, Y.S., Lee, H.J. et al., 3, 4, 5-Trihydroxycinnamic acid inhibits lipopolysaccharide-induced inflammatory response through the activation of Nrf2 pathway in BV2 microglial cells. Biomol. Ther., 21, 2013, 60.
93. Lee, D.S., Kim, K.S., Ko, W., Li, B., Keo, S., Jeong, G.S. et al., The Neoflavonoid latifolin isolated from MeOH extract of Dalbergia odorifera attenuates inflammatory responses by inhibiting NF-κB activation via Nrf2-mediated heme oxygenase-1 expression. Phytother. Res. 28 (2014), 1216–1223.
94. Lee, S., Choi, S.Y., Choo, Y.Y., Kim, O., Tran, P.T., Dao, C.T. et al., Sappanone A exhibits anti-inflammatory effects via modulation of Nrf2 and NF-κB. Int. Immunopharmacol. 28 (2015), 328–336.
95. Lee, D.S., Yoon, C.S., Jung, Y.T., Yoon, J.H., Kim, Y.C., Oh, H., Marine-derived secondary metabolite, griseusrazin a, suppresses inflammation through heme oxygenase-1 induction in activated RAW264. 7 macrophages. J. Nat. Prod. 79 (2016), 1105–1111.
96. Li, Y., Lv, O., Zhou, F., Li, Q., Wu, Z., Zheng, Y., Linalool inhibits LPS-induced inflammation in BV2 microglia cells by activating Nrf2. Neurochem. Res. 40 (2015), 1520–1525.
97. Li, C., Zhang, W.J., Frei, B., Quercetin inhibits LPS-induced adhesion molecule expression and oxidant production in human aortic endothelial cells by p38-mediated Nrf2 activation and antioxidant enzyme induction. Redox Biol. 9 (2016), 104–113.
98. Li, J., Tong, D., Liu, J., Chen, F., Shen, Y., Oroxylin A attenuates cigarette smoke-induced lung inflammation by activating Nrf2. Int. Immunopharmacol. 40 (2016), 524–529.
99. Li, M., Liu, X., He, Y., Zheng, Q., Wang, M., Wu, Y. et al., Celastrol attenuates angiotensin II mediated human umbilical vein endothelial cells damage through activation of Nrf2/ERK1/2/Nox2 signal pathway. Eur. J. Pharmacol. 797 (2017), 124–133.
100. Lin, W., Shen, G., Yuan, X., Jain, M.R., Yu, S., Zhang, A. et al., Regulation of Nrf2 transactivation domain activity by p160 RAC3/SRC3 and other nuclear co-regulators. BMB Rep. 39 (2006), 304–310.
101. Lin, W., Wu, R.T., Wu, T., Khor, T.O., Wang, H., Kong, A.N., Sulforaphane suppressed LPS-induced inflammation in mouse peritoneal macrophages through Nrf2 dependent pathway. Biochem. Pharmacol. 76 (2008), 967–973.
102. Liu, C.M., Ma, J.Q., Xie, W.R., Liu, S.S., Feng, Z.J., Zheng, G.H. et al., Quercetin protects mouse liver against nickel-induced DNA methylation and inflammation associated with the Nrf2/HO-1 and p38/STAT1/NF-κB pathway. Food Chem. Toxicol. 82 (2015), 19–26.
103. Liu, L., Shang, Y., Li, M., Han, X., Wang, J., Wang, J., Curcumin ameliorates asthmatic airway inflammation by activating nuclear factor-E2-related factor 2/haem oxygenase (HO)-1 signalling pathway. Clin. Exp. Pharmacol. Physiol. 42 (2015), 520–529.
104. Liu, X., Yu, D., Wang, T., Sappanone A attenuates allergic airway inflammation in ovalbumin-induced asthma. Int. Arch. Allergy Immunol. 170 (2016), 180–186.
105. Lu, S.H., Hsu, W.L., Chen, T.H., Chou, T.C., Activation of Nrf2/HO-1signaling pathway involves the anti-inflammatory activity of magnolol in Porphyromonas gingivalis lipopolysaccharide-stimulated mouse RAW 264.7 macrophages. Int. Immunopharmacol. 29 (2015), 770–778.
106. Lu, Y.F., Liu, J., Wu, K.C., Klaassen, C.D., Protection against phalloidin-induced liver injury by oleanolic acid involves Nrf2 activation and suppression of Oatp1b2. Toxicol. Lett. 232 (2015), 326–332.
107. Lu, C., Xu, W., Shao, J., Zhang, F., Chen, A., Zheng, S., Nrf2 activation is required for ligustrazine to inhibit hepatic steatosis in alcohol-preferring mice and hepatocytes. Toxicol. Sci. 155 (2016), 432–443.
108. Luo, Y., Eggler, A.L., Liu, D., Liu, G., Mesecar, A.D., van Breemen, R.B., Sites of alkylation of human Keap1 by natural chemoprevention agents. J. Am. Soc. Mass Spectrom. 18 (2007), 2226–2232.
109. Lv, H., Ren, W., Zheng, Y., Wang, L., Lu, G., Yi, P. et al., Tenuigenin exhibits anti-inflammatory activity via inhibiting MAPK and NF-κB and inducing Nrf2/HO-1 signaling in macrophages. Food Funct. 7 (2016), 355–363.
110. Ma, Q., Role of nrf2 in oxidative stress and toxicity. Annu. Rev. Pharmacol. Toxicol. 53 (2013), 401–426.
111. Manchope, M.F., Calixto-Campos, C., Coelho-Silva, L., Zarpelon, A.C., Pinho-Ribeiro, F.A., Georgetti, S.R. et al., Naringenin inhibits superoxide anion-induced inflammatory pain: role of oxidative stress, cytokines, Nrf-2 and the NO − cGMP − PKG − KATPchannel signaling pathway. PLoS One, 11, 2016, e0153015.
112. Mankan, A.K., Dau, T., Jenne, D., Hornung, V., The NLRP3/ASC/Caspase-1 axis regulates IL-1β processing in neutrophils. Eur. J. Immunol. 42 (2012), 710–715.
113. McMahon, M., Thomas, N., Itoh, K., Yamamoto, M., Hayes, J.D., Redox-regulated turnover of Nrf2 is determined by at least two separate protein domains, the redox-sensitive Neh2 degron and the redox-insensitive Neh6 degron. J. Biol. Chem. 279 (2004), 31556–31567.
114. Medvedev, R., Ploen, D., Spengler, C., Elgner, F., Ren, H., Bunten, S. et al., HCV-induced oxidative stress by inhibition of Nrf2 triggers autophagy and favors release of viral particles. Free Radic. Biol. Med. 110 (2017), 300–315.
115. Milkovic, L., Zarkovic, N., Saso, L., Controversy about pharmacological modulation of Nrf2 for cancer therapy. Redox Biol. 12 (2017), 727–732.
116. Minnicozzi, M., Sawyer, R.T., Fenton, M.J., Innate immunity in allergic disease. Immunol. Rev. 242 (2011), 106–127.
117. Mitter, S.K., Song, C., Qi, X., Mao, H., Rao, H., Akin, D. et al., Dysregulated autophagy in the RPE is associated with increased susceptibility to oxidative stress and AMD. Autophagy 10 (2014), 1989–2005.
118. Mo, C., Wang, L., Zhang, J., Numazawa, S., Tang, H., Tang, X. et al., The crosstalk between Nrf2 and AMPK signal pathways is important for the anti-inflammatory effect of berberine in LPS-stimulated macrophages and endotoxin-shocked mice. Antioxid. Redox Signal. 20 (2014), 574–588.
119. Mogensen, T.H., Pathogen recognition and inflammatory signaling in innate immune defenses. Clin. Microbiol. Rev. 22 (2009), 240–273.
120. Moi, P., Chan, K., Asunis, I., Cao, A., Kan, Y.W., Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Proc. Natl. Acad. Sci. U. S. A. 91 (1994), 9926–9930.
121. Morzadec, C., Macoch, M., Sparfel, L., Kerdine-Romer, S., Fardel, O., Vernhet, L., Nrf2 expression and activity in human T lymphocytes: stimulation by T cell receptor activation and priming by inorganic arsenic and tert-butylhydroquinone. Free Radic. Biol. Med. 71 (2014), 133–145.
122. Mota, S.I., Costa, R.O., Ferreira, I.L., Santana, I., Caldeira, G.L., Padovano, C. et al., Oxidative stress involving changes in Nrf2 and ER stress in early stages of Alzheimer's disease. Biochim. Biophys. Acta 1852 (2015), 1428–1441.
123. Mozzini, C., Fratta Pasini, A., Garbin, U., Stranieri, C., Pasini, A., Vallerio, P. et al., Increased endoplasmic reticulum stress and Nrf2 repression in peripheral blood mononuclear cells of patients with stable coronary artery disease. Free Radic. Biol. Med. 68 (2014), 178–185.
124. Mozzini, C., Cominacini, L., Garbin, U., Fratta Pasini, A.M., Endoplasmic reticulum stress, NRF2 signalling and cardiovascular diseases in a nutshell. Curr Atheroscler Rep, 19(33), 2017.
125. Murphy, K.E., Park, J.J., Can co-activation of Nrf2 and neurotrophic signaling pathway slow Alzheimer's disease?. Int. J. Mol. Sci., 18, 2017.
126. Nagai, N., Thimmulappa, R.K., Cano, M., Fujihara, M., Izumi-Nagai, K., Kong, X. et al., Nrf2 is a critical modulator of the innate immune response in a model of uveitis. Free Radic. Biol. Med. 47 (2009), 300–306.
127. Nakagami, Y., Nrf2 is an attractive therapeutic target for retinal diseases. Oxidative Med. Cell. Longev., 2016(7469326), 2016.
128. Negash, A.A., Ramos, H.J., Crochet, N., Lau, D.T., Doehle, B., Papic, N. et al., IL-1β production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease. PLoS Pathog., 9, 2013, e1003330.
129. Netea, M., Veerdonk, F., Meer, J., Primary immunodeficiencies of pattern recognition receptors. J. Intern. Med. 272 (2012), 517–527.
130. Nguyen, T., Sherratt, P.J., Huang, H.C., Yang, C.S., Pickett, C.B., Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element degradation of Nrf2 by the 26 S proteasome. J. Biol. Chem. 278 (2003), 4536–4541.
131. Nguyen, T., Sherratt, P.J., Pickett, C.B., Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu. Rev. Pharmacol. Toxicol. 43 (2003), 233–260.
132. Nguyen, T., Sherratt, P.J., Nioi, P., Yang, C.S., Pickett, C.B., Nrf2 controls constitutive and inducible expression of ARE-driven genes through a dynamic pathway involving nucleocytoplasmic shuttling by Keap1. J. Biol. Chem. 280 (2005), 32485–32492.
133. Nioi, P., Hayes, J.D., Contribution of NAD (P) H: quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loop-helix transcription factors. Mutat. Res. 555 (2004), 149–171.
134. Niture, S.K., Jain, A.K., Jaiswal, A.K., Antioxidant-induced modification of INrf2 cysteine 151 and PKC-delta-mediated phosphorylation of Nrf2 serine 40 are both required for stabilization and nuclear translocation of Nrf2 and increased drug resistance. J. Cell Sci. 122 (2009), 4452–4464.
135. Niture, S.K., Kaspar, J.W., Shen, J., Jaiswal, A.K., Nrf2 signaling and cell survival. Toxicol. Appl. Pharmacol. 244 (2010), 37–42.
136. Ogura, T., Tong, K.I., Mio, K., Maruyama, Y., Kurokawa, H., Sato, C. et al., Keap1 is a forked-stem dimer structure with two large spheres enclosing the intervening, double glycine repeat, and C-terminal domains. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 2842–2847.
137. Olagnier, D., Lababidi, R.R., Hadj, S.B., Sze, A., Liu, Y., Naidu, S.D. et al., Activation of Nrf2 signaling augments vesicular stomatitis virus oncolysis via autophagy-driven suppression of antiviral immunity. Mol. Ther. 25:8 (2017), 1900–1916.
138. de Oliveira, M.R., da Costa Ferreira, G., Brasil, F.B., Peres, A., Pinocembrin suppresses H2O2-induced mitochondrial dysfunction by a mechanism dependent on the Nrf2/HO-1 axis in SH-SY5Y Cells. Mol. Neurobiol., 2017, 10.1007/s12035-016-0380-7.
139. de Oliveira, M.R., de Souza, I.C.C., Fürstenau, C.R., Carnosic acid induces anti-inflammatory effects in paraquat-treated SH-SY5Y cells through a mechanism involving a crosstalk between the Nrf2/HO-1 axis and NF-κB. Mol. Neurobiol., 2017, 10.1007/s12035-017-0389-6.
140. de Oliveira, M.R., Peres, A., Ferreira, G.C., Schuck, P.F., Gama, C.S., Dal Bosco, S.M., Carnosic acid protects mitochondria of human neuroblastoma SH-SY5Y cells exposed to paraquat through activation of the Nrf2/HO-1Axis. Mol. Neurobiol. 54:8 (2017), 5961–5972.
141. Panchal, S.K., Poudyal, H., Brown, L., Quercetin ameliorates cardiovascular, hepatic, and metabolic changes in diet-induced metabolic syndrome in rats. J. Nutr. 142 (2012), 1026–1032.
142. Peng, S., Zhang, B., Meng, X., Yao, J., Fang, J., Synthesis of piperlongumine analogues and discovery of nuclear factor erythroid 2-related factor 2 (Nrf2) activators as potential neuroprotective agents. J. Med. Chem. 58 (2015), 5242–5255.
143. Peng, Z., Wang, S., Chen, G., Liu, R., Deng, J., Liu, J. et al., Gastrodin alleviates cerebral ischemic damage in mice by improving anti-oxidant and anti-inflammation activities and inhibiting apoptosis pathway. Neurochem. Res. 40 (2015), 661–673.
144. Pistollato, F., Canovas-Jorda, D., Zagoura, D., Bal-Price, A., Nrf2 pathway activation upon rotenone treatment in human iPSC-derived neural stem cells undergoing differentiation towards neurons and astrocytes. Neurochem. Int. 108 (2017), 457–471.
145. Plafker, K.S., Nguyen, L., Barneche, M., Mirza, S., Crawford, D., Plafker, S.M., The ubiquitin-conjugating enzyme UbcM2 can regulate the stability and activity of the antioxidant transcription factor Nrf2. J. Biol. Chem. 285 (2010), 23064–23074.
146. Plafker, K.S., Nguyen, L., Barneche, M., Mirza, S., Crawford, D., Plafker, S.M., The ubiquitin-conjugating enzyme UbcM2 can regulate the stability and activity of the antioxidant transcription factor Nrf2. J. Biol. Chem. 285 (2010), 23064–23074.
147. Qin, T., Du, R., Huang, F., Yin, S., Yang, J., Qin, S. et al., Sinomenine activation of Nrf2 signaling prevents hyperactive inflammation and kidney injury in a mouse model of obstructive nephropathy. Free Radic. Biol. Med. 92 (2016), 90–99.
148. Qu, L.L., Yu, B., Li, Z., Jiang, W.X., Jiang, J.D., Kong, W.J., Gastrodin ameliorates oxidative stress and proinflammatory response in nonalcoholic fatty liver disease through the AMPK/Nrf2 pathway. Phytother. Res. 30 (2016), 402–411.
149. Ramsey, C.P., Glass, C.A., Montgomery, M.B., Lindl, K.A., Ritson, G.P., Chia, L.A. et al., Expression of Nrf2 in neurodegenerative diseases. J. Neuropathol. Exp. Neurol. 66 (2007), 75–85.
150. Ramsey, C.P., Glass, C.A., Montgomery, M.B., Lindl, K.A., Ritson, G.P., Chia, L.A. et al., Expression of Nrf2 in neurodegenerative diseases. J. Neuropathol. Exp. Neurol. 66 (2007), 75–85.
151. Rangasamy, T., Guo, J., Mitzner, W.A., Roman, J., Singh, A., Fryer, A.D. et al., Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice. J. Exp. Med. 202 (2005), 47–59.
152. Ren, H., Hao, J., Liu, T., Zhang, D., Lv, H., Song, E. et al., Hesperetin suppresses inflammatory responses in lipopolysaccharide-induced RAW 264.7 cells via the inhibition of NF-κB and activation of Nrf2/HO-1 pathways. Inflammation 39 (2016), 964–973.
153. Ruotsalainen, A.K., Inkala, M., Partanen, M.E., Lappalainen, J.P., Kansanen, E., Makinen, P.I. et al., The absence of macrophage Nrf2 promotes early atherogenesis. Cardiovasc. Res. 98 (2013), 107–115.
154. Rushmore, T.H., Morton, M.R., Pickett, C.B., The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J. Biol. Chem. 266 (1991), 11632–11639.
155. Sahin, K., Tuzcu, M., Gencoglu, H., Dogukan, A., Timurkan, M., Sahin, N. et al., Epigallocatechin-3-gallate activates Nrf2/HO-1 signaling pathway in cisplatin-induced nephrotoxicity in rats. Life Sci. 87 (2010), 240–245.
156. Sahin, K., Tuzcu, M., Sahin, N., Ali, S., Kucuk, O., Nrf2/HO-1 signaling pathway may be the prime target for chemoprevention of cisplatin-induced nephrotoxicity by lycopene. Food Chem. Toxicol. 48 (2010), 2670–2674.
157. Sahu, B.D., Kumar, J.M., Kuncha, M., Borkar, R.M., Srinivas, R., Sistla, R., Baicalein alleviates doxorubicin-induced cardiotoxicity via suppression of myocardial oxidative stress and apoptosis in mice. Life Sci. 144 (2016), 8–18.
158. Seo, S.H., Jeong, G.S., Fisetin inhibits TNF-α-induced inflammatory action and hydrogen peroxide-induced oxidative damage in human keratinocyte HaCaT cells through PI3K/AKT/Nrf-2-mediated heme oxygenase-1 expression. Int. Immunopharmacol. 29 (2015), 246–253.
159. Seo, K., Yang, J.H., Kim, S.C., Ku, S.K., Ki, S.H., Shin, S.M., The antioxidant effects of isorhamnetin contribute to inhibit COX-2 expression in response to inflammation: a potential role of HO-1. Inflammation 37 (2014), 712–722.
160. Shrivastava, S., Devhare, P., Sujijantarat, N., Steele, R., Kwon, Y.C., Ray, R. et al., Knockdown of autophagy inhibits infectious hepatitis C virus release by the exosomal pathway. J. Virol. 90 (2016), 1387–1396.
161. Sies, H., Berndt, C., Jones, D.P., Oxidative stress. Annu. Rev. Biochem. 86 (2017), 715–748.
162. Slocum, S.L., Kensler, T.W., Nrf2: control of sensitivity to carcinogens. Arch. Toxicol. 85 (2011), 273–284.
163. Soares, M.P., Seldon, M.P., Gregoire, I.P., Vassilevskaia, T., Berberat, P.O., Yu, J. et al., Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation. J. Immunol. 172 (2004), 3553–3563.
164. Sriram, N., Kalayarasan, S., Sudhandiran, G., Epigallocatechin-3-gallate augments antioxidant activities and inhibits inflammation during bleomycin-induced experimental pulmonary fibrosis through Nrf2–Keap1 signaling. Pulm. Pharmacol. Ther. 22 (2009), 221–236.
165. Staitieh, B.S., Ding, L., Neveu, W.A., Spearman, P., Guidot, D.M., Fan, X., HIV-1 decreases Nrf2/ARE activity and phagocytic function in alveolar macrophages. J. Leukoc. Biol. 102:2 (2017), 517–525.
166. Sun, Z., Zhang, S., Chan, J.Y., Zhang, D.D., Keap1 controls postinduction repression of the Nrf2-mediated antioxidant response by escorting nuclear export of Nrf2. Mol. Cell. Biol. 27 (2007), 6334–6349.
167. Sun, G.Y., Chen, Z., Jasmer, K.J., Chuang, D.Y., Gu, Z., Hannink, M. et al., Quercetin attenuates inflammatory responses in BV-2 microglial cells: role of MAPKs on the Nrf2 pathway and induction of heme oxygenase-1. PLoS One, 10, 2015, e0141509.
168. Suresh, R., Mosser, D.M., Pattern recognition receptors in innate immunity, host defense, and immunopathology. Adv. Physiol. Educ. 37 (2013), 284–291.
169. Suzuki, T., Motohashi, H., Yamamoto, M., Toward clinical application of the Keap1–Nrf2 pathway. Trends Pharmacol. Sci. 34 (2013), 340–346.
170. Sykiotis, G.P., Bohmann, D., Stress-activated cap'n'collar transcription factors in aging and human disease. Sci. Signal., 3, 2010, re3.
171. Thiel, G., Rössler, O.G., Resveratrol regulates gene transcription via activation of stimulus-responsive transcription factors. Pharmacol. Res. 117 (2017), 166–176.
172. Thimmulappa, R.K., Lee, H., Rangasamy, T., Reddy, S.P., Yamamoto, M., Kensler, T.W. et al., Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J. Clin. Invest. 116 (2006), 984–995.
173. Tong, K.I., Kobayashi, A., Katsuoka, F., Yamamoto, M., Two-site substrate recognition model for the Keap1-Nrf2 system: a hinge and latch mechanism. Biol. Chem. 387 (2006), 1311–1320.
174. Tong, K.I., Padmanabhan, B., Kobayashi, A., Shang, C., Hirotsu, Y., Yokoyama, S. et al., Different electrostatic potentials define ETGE and DLG motifs as hinge and latch in oxidative stress response. Mol. Cell. Biol. 27 (2007), 7511–7521.
175. Tsai, C.L., Lin, Y.C., Wang, H.M., Chou, T.C., Baicalein, an active component of Scutellaria baicalensis, protects against lipopolysaccharide-induced acute lung injury in rats. J. Ethnopharmacol. 153 (2014), 197–206.
176. Tu, Z.S., Wang, Q., Sun, D.D., Dai, F., Zhou, B., Design, synthesis, and evaluation of curcumin derivatives as Nrf2 activators and cytoprotectors against oxidative death. Eur. J. Med. Chem. 134 (2017), 72–85.
177. Uruno, A., Motohashi, H., The Keap1-Nrf2 system as an in vivo sensor for electrophiles. Nitric Oxide 25 (2011), 153–160.
178. Venugopal, R., Jaiswal, A.K., Nrf2 and Nrf1 in association with Jun proteins regulate antioxidant response element-mediated expression and coordinated induction of genes encoding detoxifying enzymes. Oncogene, 17, 1998.
179. Wall, S.B., Smith, M.R., Ricart, K., Zhou, F., Vayalil, P.K., Oh, J.Y. et al., Detection of electrophile-sensitive proteins. Biochim. Biophys. Acta 1840 (2014), 913–922.
180. Wang, H., Liu, K., Geng, M., Gao, P., Wu, X., Hai, Y. et al., RXRalpha inhibits the NRF2-ARE signaling pathway through a direct interaction with the Neh7 domain of NRF2. Cancer Res. 73 (2013), 3097–3108.
181. Wang, Y., Wang, B., Du, F., Su, X., Sun, G., Zhou, G. et al., Epigallocatechin-3-Gallate attenuates oxidative stress and inflammation in obstructive nephropathy via NF-κB and Nrf2/HO-1 signalling pathway regulation. Basic Clin. Pharmacol. Toxicol. 117 (2015), 164–172.
182. Wang, Y., Huo, Y., Zhao, L., Lu, F., Wang, O., Yang, X. et al., Cyanidin-3-glucoside and its phenolic acid metabolites attenuate visible light-induced retinal degeneration in vivo via activation of Nrf2/HO-1 pathway and NF-κB suppression. Mol. Nutr. Food Res. 60 (2016), 1564–1577.
183. Wang, Y., Zhao, H., Lin, C., Ren, J., Zhang, S., Forsythiaside A exhibits anti-inflammatory effects in LPS-stimulated BV2 microglia cells through activation of Nrf2/HO-1 signaling pathway. Neurochem. Res. 41 (2016), 659–665.
184. Wang, Z., Sun, D., Chen, G., Li, G., Dou, S., Wang, R. et al., Tim-3 inhibits macrophage control of Listeria monocytogenes by inhibiting Nrf2. Sci. Rep., 7, 2017, 42095.
185. Wilson, A.J., Kerns, J.K., Callahan, J.F., Moody, C.J., Keap calm, and carry on covalently. J. Med. Chem. 56 (2013), 7463–7476.
186. Wong, M.H., Bryan, H.K., Copple, I.M., Jenkins, R.E., Chiu, P.H., Bibby, J. et al., Design and synthesis of irreversible analogues of bardoxolone methyl for the identification of pharmacologically relevant targets and interaction sites. J. Med. Chem. 59 (2016), 2396–2409.
187. Woo, S.Y., Kim, J.H., Moon, M.K., Han, S.H., Yeon, S.K., Choi, J.W. et al., Discovery of vinyl sulfones as a novel class of neuroprotective agents toward Parkinson's disease therapy. J. Med. Chem. 57 (2014), 1473–1487.
188. Wu, X.L., Liou, C.J., Li, Z.Y., Lai, X.Y., Fang, L.W., Huang, W.C., Sesamol suppresses the inflammatory response by inhibiting NF-κB/MAPK activation and upregulating AMP kinase signaling in RAW 264.7 macrophages. Inflamm. Res. 64 (2015), 577–588.
189. Wu, J., Ren, J., Yao, S., Wang, J., Huang, L., Zhou, P. et al., Novel antioxidants’ synthesis and their anti-oxidative activity through activating Nrf2 signaling pathway. Bioorg. Med. Chem. Lett. 27 (2017), 1616–1619.
190. Wu, J., Xu, L., Sun, C., Zhang, B., Li, J., Sun, J. et al., Paeonol alleviates epirubicin-induced renal injury in mice by regulating Nrf2 and NF-κB pathways. Eur. J. Pharmacol. 795 (2017), 84–93.
191. Xiong, N., Long, X., Xiong, J., Jia, M., Chen, C., Huang, J. et al., Mitochondrial complex I inhibitor rotenone-induced toxicity and its potential mechanisms in Parkinson's disease models. Crit. Rev. Toxicol. 42 (2012), 613–632.
192. Xu, L.L., Zhu, J.F., Xu, X.L., Zhu, J., Li, L., Xi, M.Y. et al., Discovery and modification of in vivo active Nrf2 activators with 1,2,4-oxadiazole core: hits identification and structure-activity relationship study. J. Med. Chem. 58 (2015), 5419–5436.
193. Xu, X., Li, H., Hou, X., Li, D., He, S., Wan, C. et al., Punicalagin induces Nrf2/HO-1 expression via upregulation of PI3K/AKT pathway and inhibits LPS-induced oxidative stress in RAW264. 7 macrophages. Mediat. Inflamm., 2015, 2015, 380218.
194. Xu, L.L., Zhang, X., Jiang, Z.Y., You, Q.D., Molecular similarity guided optimization of novel Nrf2 activators with 1,2,4-oxadiazole core. Bioorg. Med. Chem. 24 (2016), 3540–3547.
195. Yan, T., Yu, X., Sun, X., Meng, D., Jia, J.M., A new steroidal saponin, furotrilliumoside from Trillium tschonoskii inhibits lipopolysaccharide-induced inflammation in Raw264. 7 cells by targeting PI3K/Akt, MARK and Nrf2/HO-1 pathways. Fitoterapia 115 (2016), 37–45.
196. Yang, D., Tan, X., Lv, Z., Liu, B., Baiyun, R., Lu, J. et al., Regulation of Sirt1/Nrf2/TNF-α signaling pathway by luteolin is critical to attenuate acute mercuric chloride exposure induced hepatotoxicity. Sci. Rep., 6(37157), 2016.
197. Yu, X., Kensler, T., Nrf2 as a target for cancer chemoprevention. Mutat. Res. 591 (2005), 93–102.
198. Yu, R., Mandlekar, S., Lei, W., Fahl, W.E., Tan, T.H., Kong, A.N.T., p38 mitogen-activated protein kinase negatively regulates the induction of phase II drug-metabolizing enzymes that detoxify carcinogens. J. Biol. Chem. 275 (2000), 2322–2327.
199. Zagoura, D., Canovas-Jorda, D., Pistollato, F., Bremer-Hoffmann, S., Bal-Price, A., Evaluation of the rotenone-induced activation of the Nrf2 pathway in a neuronal model derived from human induced pluripotent stem cells. Neurochem. Int. 106 (2017), 62–73.
200. Zenkov, N.K., Kozhin, P.M., Chechushkov, A.V., Martinovich, G.G., Kandalintseva, N.V., Menshchikova, E.B., Mazes of Nrf2 regulation. Biochem. Biokhimiia 82 (2017), 556–564.
201. Zhang, D.D., Hannink, M., Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol. Cell. Biol. 23 (2003), 8137–8151.
202. Zhang, B., Niu, W., Xu, D., Li, Y., Liu, M., Wang, Y. et al., Oxymatrine prevents hypoxia-and monocrotaline-induced pulmonary hypertension in rats. Free Radic. Biol. Med. 69 (2014), 198–207.
203. Zhang, X., Jiang, A., Qi, B., Ma, Z., Xiong, Y., Dou, J. et al., Resveratrol protects against Helicobacter pylori-associated gastritis by combating oxidative stress. Int. J. Mol. Sci. 16 (2015), 27757–27769.
204. Zhang, R., Xu, M., Wang, Y., Xie, F., Zhang, G., Qin, X., Nrf2—a promising therapeutic target for defensing against oxidative stress in stroke. Mol. Neurobiol., 2016, 10.1007/s12035-016-0111-0.
205. Zhang, J., Sheng, Y., Shi, L., Zheng, Z., Chen, M., Lu, B. et al., Quercetin and baicalein suppress monocrotaline-induced hepatic sinusoidal obstruction syndrome in rats. Eur. J. Pharmacol. 795 (2017), 160–168.
206. Zhao, M., Chen, J., Zhu, P., Fujino, M., Takahara, T., Toyama, S. et al., Dihydroquercetin (DHQ) ameliorated concanavalin A-induced mouse experimental fulminant hepatitis and enhanced HO-1 expression through MAPK/Nrf2 antioxidant pathway in RAW cells. Int. Immunopharmacol. 28 (2015), 938–944.
207. Zhao, J.J., Song, J.Q., Pan, S.Y., Wang, K., Treatment with isorhamnetin protects the brain against ischemic injury in mice. Neurochem. Res. 41 (2016), 1939–1948.
208. Zhou, L.T., Wang, K.J., Li, L., Li, H., Geng, M., Pinocembrin inhibits lipopolysaccharide-induced inflammatory mediators production in BV2 microglial cells through suppression of PI3K/Akt/NF-κB pathway. Eur. J. Pharmacol. 761 (2015), 211–216.
209. Zipper, L.M., Mulcahy, R.T., The Keap1 BTB/POZ dimerization function is required to sequester Nrf2 in cytoplasm. J. Biol. Chem. 277 (2002), 36544–36552.
210. Zong, Y., Zhang, H., Amentoflavone prevents sepsis-associated acute lung injury through Nrf2-GCLc-mediated upregulation of glutathione. Acta Biochim. Pol. 64 (2016), 93–98.